All questionsIndication: Foundayo (orforglipron) in chronic weight management5 questions · 2 sourcesIndicationWhat is Foundayo approved for?“FOUNDAYOTM is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.” (opens the source at this quote in a new tab)CopyFlag“Limitations of Use Concomitant use with another GLP-1 receptor agonist is not recommended.” (opens the source at this quote in a new tab)CopyFlagWhat year was Foundayo approved by the FDA?“Initial U.S. Approval: 2026” (opens the source at this quote in a new tab)CopyFlagIs Foundayo approved for cosmetic weight loss?“Foundayo is not indicated for cosmetic weight loss.” (opens the source at this quote in a new tab)CopyFlagDrug namesWhat is the generic name of Foundayo?“FOUNDAYO- orforglipron tablet, film coated” (opens the source at this quote in a new tab)CopyFlag“FOUNDAYO (orforglipron) tablets, for oral use” (opens the source at this quote in a new tab)CopyFlagHow do you pronounce Foundayo?“FOUNDAYO™ [fown-DAY-oh] (orforglipron)” (opens the source at this quote in a new tab)CopyFlagNote: This line is from the Medication Guide printed with the Prescribing Information.